» Articles » PMID: 8748273

Application of CHROMagar Candida for Rapid Screening of Clinical Specimens for Candida Albicans, Candida Tropicalis, Candida Krusei, and Candida (Torulopsis) Glabrata

Overview
Specialty Microbiology
Date 1996 Jan 1
PMID 8748273
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

CHROMagar Candida is a new differential culture medium that allows selective isolation of yeasts and simultaneously identifies colonies of Candida albicans, C. tropicalis, and C. krusei. We evaluated the use of this medium with 316 yeast isolates including 247 isolated directly on CHROMagar from clinical material. Over 95% of stock and clinical isolates of C. albicans, C. tropicalis, and C. krusei were correctly identified on the basis of colony morphology and pigmentation on CHROMagar. Additionally, CHROMagar also allowed the identification of C. (Torulopsis) glabrata at a similar level of accuracy. The overall agreement between two observers in reading the CHROMagar plates was 95%. Growth of Candida sp. isolates on CHROMagar had no adverse effect on antifungal MICs or Vitek identification results. In parallel, cultures of 548 stool and rectal swab specimens set up on CHROMagar and Sabouraud glucose agar (SGA) were positive in 234 instances. CHROMagar was positive and SGA was negative for 11 specimens, and CHROMagar was negative and SGA was positive for 18 specimens. A single yeast species was isolated on both media from 162 specimens, and in 146 (90%) of these specimens the same species was detected on both CHROMagar and SGA. A total of 43 of the 234 positive cultures contained mixtures of yeast species. Twenty (47%) of these mixed cultures were detected only on CHROMagar. CHROMagar is extremely useful in making a rapid presumptive identification of common yeast species. This capability plus the ability to detect mixed cultures of Candida spp. promises to improve and streamline the work flow in the mycology and clinical microbiology laboratory.

Citing Articles

Evaluation of the Anticandidal Effect of Medicinal Plant Extracts to Drug Resistant Isolates from Type Two Diabetic patients with Stage Three Periodontitis.

Prabhakaran J, Varghese N, Rupesh S, Thomas A, Sameer K, Thomas N J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4532-S4535.

PMID: 40061650 PMC: 11888649. DOI: 10.4103/jpbs.jpbs_1143_24.


Streamlined chemical fixation method for morphological investigation of with scanning electron microscopy.

Ramirez-Camacho M, Beltran-Partida E, Valdez-Salas B, Curiel Alvarez M MethodsX. 2024; 13:102985.

PMID: 39430777 PMC: 11490910. DOI: 10.1016/j.mex.2024.102985.


Hospitalized COVID-19 Patients with Urinary Tract Infection in Iran: Species Distribution and Antifungal Susceptibility Patterns.

Shiyadeh Z, Farahyar S, Vahedi Larijani L, Beardsley J, Nouri N, Mahmoudi S Antibiotics (Basel). 2024; 13(7).

PMID: 39061315 PMC: 11273823. DOI: 10.3390/antibiotics13070633.


Affects Virulence by Limiting Its Capacity to Adhere to the Host Intestinal Surface, Leading to Decreased Susceptibility to Colitis in Mice.

Roberts K, Osme A, De Salvo C, Zoli E, Herrada J, McCormick T J Fungi (Basel). 2024; 10(4).

PMID: 38667916 PMC: 11051055. DOI: 10.3390/jof10040245.


Evaluation of CHROMagar Plus for the detection of with a panel of 206 fungal isolates and 83 colonization screening skin-swabs.

Bentz M, Le N, Min B, Nunnally N, Sullivan V, Tran M Microbiol Spectr. 2024; 12(4):e0356423.

PMID: 38364098 PMC: 10986463. DOI: 10.1128/spectrum.03564-23.


References
1.
Sandford G, Merz W, Wingard J, CHARACHE P, Saral R . The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis. 1980; 142(4):503-9. DOI: 10.1093/infdis/142.4.503. View

2.
Pfaller M, Cabezudo I, Koontz F, Bale M, Gingrich R . Predictive value of surveillance cultures for systemic infection due to Candida species. Eur J Clin Microbiol. 1987; 6(6):628-33. DOI: 10.1007/BF02013057. View

3.
Pfaller M, Preston T, Bale M, Koontz F, Body B . Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol. 1988; 26(10):2054-8. PMC: 266815. DOI: 10.1128/jcm.26.10.2054-2058.1988. View

4.
Reagan D, Pfaller M, Hollis R, Wenzel R . Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol. 1990; 28(12):2733-8. PMC: 268264. DOI: 10.1128/jcm.28.12.2733-2738.1990. View

5.
Voss A, Hollis R, Pfaller M, Wenzel R, Doebbeling B . Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol. 1994; 32(4):975-80. PMC: 267165. DOI: 10.1128/jcm.32.4.975-980.1994. View